Interventional treatment combined with immunotargeted therapy in unresectable combined hepatocellular-cholangiocarcinoma: a real-world retrospective cohort study

Interventional treatment combined with immunotargeted therapy in unresectable combined hepatocellular-cholangiocarcinoma: a real-world retrospective cohort study

BackgroundEvidence-based treatment for unresectable combined hepatocellular-cholangiocarcinoma (cHCC-CCA) has not been established. This study aimed to assess the effectiveness and safety of interventional treatment combined with immunotargeted therapy (IIT) in unresectable cHCC-CCA patients.Methods...

Full description

Saved in:
Bibliographic Details
Main Authors: Yan-Song Lin, Li-Yan Wu, Li-Hui Lin, Xia Yang, Fang-Yi Liu, Yan-Qin Wu, Zhen Ding, Yu-Jing Liang, Jing-Ping Yun
Format: Article
Language:English
Published: Frontiers Media S.A. 2025-07-01
Series:Frontiers in Immunology
Subjects:
interventional treatment
PD-(L)1 inhibitor
targeted therapy
unresectable combined hepatocellular-cholangiocarcinoma
outcome
Online Access:https://www.frontiersin.org/articles/10.3389/fimmu.2025.1591127/full
Tags: Add Tag
No Tags, Be the first to tag this record!

Internet

https://www.frontiersin.org/articles/10.3389/fimmu.2025.1591127/full

Similar Items